XML 80 R55.htm IDEA: XBRL DOCUMENT v3.6.0.2

Segment reporting (Tables)

12 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes

The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:

		Year ended December 31,
		2016				2015				2014
Segment revenues:
U.S. dialysis and related lab services
Patient service revenues:
External sources		$	9,482,648			$	8,980,515			$	8,513,089
Intersegment revenues			68,774				53,476				37,112
Total dialysis and related lab services revenues			9,551,422				9,033,991				8,550,201
Less: Provision for uncollectible accounts			(429,882	)			(406,530	)			(353,028	)
Net dialysis and related lab services patient service revenues			9,121,540				8,627,461				8,197,173
Other revenues(1)			16,649				13,971				13,498
Total net dialysis and related lab services revenues			9,138,189				8,641,432				8,210,671
DMG
DMG revenues:
Capitated revenues		$	3,430,576			$	3,436,705			$	3,190,903
Net patient service revenues			621,583				317,950				219,306
Other revenues(2)			61,040				82,470				91,374
Intersegment capitated and other revenues			215				136				716
Total revenues		$	4,113,414			$	3,837,261			$	3,502,299
Other - Ancillary services and strategic initiatives
Net patient service revenues		$	228,459			$	160,484			$	122,087
Capitated revenues			88,103				72,390				70,385
Other external sources			1,245,929				1,123,882				927,492
Intersegment revenues			58,881				25,674				19,535
Total ancillary services and strategic initiatives revenues			1,621,372				1,382,430				1,139,499
Total net segment revenues			14,872,975				13,861,123				12,852,469
Elimination of intersegment revenues			(127,870	)			(79,286	)			(57,363	)
Consolidated net revenues		$	14,745,105			$	13,781,837			$	12,795,106
Segment operating margin (loss):
U.S. dialysis and related lab services		$	1,777,014			$	1,259,632			$	1,637,626
DMG			(104,233	)			33,929				214,983
Other—Ancillary services and strategic initiatives			266,323				(103,901	)			(24,456	)
Total segment margin			1,939,104				1,189,660				1,828,153
Reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:
Corporate administrative support(3)			(44,561	)			(18,965	)			(13,012	)
Consolidated operating income			1,894,543				1,170,695				1,815,141
Debt expense			(414,382	)			(408,380	)			(410,294	)
Debt refinancing and redemption charges			—				(48,072	)			(97,548	)
Other income			8,734				8,893				2,374
Consolidated income from continuing operations before income taxes		$	1,488,895			$	723,136			$	1,309,673

(1) Includes management fees for providing management and administrative services to dialysis centers in which the Company owns a noncontrolling interest or which are wholly-owned by third parties.

(2) Includes medical consulting service fees and management fees for providing management and administrative services to unconsolidated joint ventures, as well as revenue related to the maintenance of existing physician networks.

(3) Corporate administrative support costs in 2016 also include $30,934 of an adjustment to reduce a tax asset associated with the DMG acquisition escrow provisions.

Summary of Depreciation and Amortization Expense by Segment

Depreciation and amortization expense by segment is as follows:

		December 31,
		2016				2015				2014
U.S. dialysis and related lab services		$	482,768			$	438,238			$	402,767
DMG			210,755				174,118				169,485
Other - Ancillary services and strategic initiatives			26,729				25,668				18,683
		$	720,252			$	638,024			$	590,935

Summary of Assets by Segment

Summary of assets by segment is as follows:

		December 31,
		2016				2015
Segment assets
U.S. dialysis and related lab services (including equity investments of $66,924 and $29,801, respectively)		$	11,438,100			$	11,591,507
DMG (including equity investments of $10,350 and $22,714, respectively)			6,213,091				6,150,666
Other - Ancillary services and strategic initiatives(1) (including equity investments of $425,115 and $20,853, respectively)			1,090,066				772,702
Consolidated assets		$	18,741,257			$	18,514,875

(1) Includes approximately $96,396 and $ 69,519 in 2016 and 2015, respectively, of net property and equipment related to the Company’s international operations.

Summary of Expenditures for Property and Equipment by Segment

Expenditures for property and equipment by segment is as follows:

		December 31,
		2016				2015				2014
U.S. dialysis and related lab services		$	675,994			$	584,513			$	560,610
DMG			84,399				66,800				27,885
Other - Ancillary services and strategic initiatives			68,702				56,685				52,835
		$	829,095			$	707,998			$	641,330

X

- Definition

Reconciliation of capital expenditures for property and equipment from segment to consolidated.

+ References

No definition available.

+ Details

Name:	dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock
Namespace Prefix:	dva_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration